A

Researcher Profile

A. Patnaik

3

Publications

1,038

Citations

10

Co-Authors

3

Active Years

Publications

Open Access Journal Article Annals of Oncology Sep 01, 2020

525O A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies

G. Ku · J.C. Bendell · A.W. Tolcher · S.A. Hurvitz +14 more

10.1016/j.annonc.2020.08.639 27 citations

Open Access Journal Article Annals of Oncology Apr 01, 2019

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

O. Hamid · C. Robert · A. Daud · F.S. Hodi +16 more

10.1093/annonc/mdz011 793 citations

Open Access Journal Article Annals of Oncology Oct 01, 2016

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

A. Patnaik · L.J. Appleman · A.W. Tolcher · K.P. Papadopoulos +17 more

10.1093/annonc/mdw282 218 citations

Publication Timeline

2020

1

2019

1

2016

1

Frequent Co-Authors

A.B. El-Khoueiry